Proxy firm ISS urges Core Scientific shareholders to reject CoreWeave's $9B acquisition, citing undervaluation.
Core Scientific Inc. shares jumped in late trading after a key proxy adviser said a takeover bid by CoreWeave Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback